Chesler4:26
|
|
|
(none)
|
TS_frequency_climbing
47026
|
DO population w/par |
|
both |
12-16wks |
|
2013 |
| | |
|
|
Chesler4:27
|
|
|
(none)
|
TS_time_immobile
47027
|
DO population w/par |
|
both |
12-16wks |
|
2013 |
| | |
|
|
Chesler4:28
|
|
|
(none)
|
TS_latency_immobile
47028
|
DO population w/par |
|
both |
12-16wks |
|
2013 |
| | |
|
|
Gershenfeld1:1
|
|
|
(none)
|
TST_saline
16201
before injection after injection
|
inbred |
|
m |
5-10wks |
|
2003 |
| | |
|
|
Gershenfeld1:3
|
|
|
imipramine
|
TST_Rx
16203
baseline imipramine 30mg/kg
|
inbred |
|
m |
5-10wks |
|
2003 |
| | |
|
|
Gershenfeld1:5
|
|
|
imipramine
|
TST_immobility_pct
16205
|
inbred |
|
m |
5-10wks |
|
2003 |
| | |
|
|
JaxCC1:9134
|
|
|
(none)
|
immob_latency_TS
89134
|
CC |
|
both |
10-12wks |
|
2018 |
| | |
|
|
JaxCC1:9135
|
|
|
(none)
|
immob_duration_TS
89135
|
CC |
|
both |
10-12wks |
|
2018 |
| | |
|
|
JaxKOMP-EAP:235
|
|
|
(none)
|
latency to immobility, 5 min test
[s]
immob_latency_TS
latency_to_immobility
100586
|
KOMP |
|
both |
11wks |
|
2015 |
| | |
|
|
JaxKOMP-EAP:236
|
|
|
(none)
|
duration of immobility, 5 min test
[s]
immob_duration_TS
time_immobile
100587
|
KOMP |
|
both |
11wks |
|
2015 |
| | |
|
|
JaxKOMP-EAP:237
|
|
|
(none)
|
climbing, 5 min test (yes, no)
climbing
100588
categorical
|
KOMP |
|
both |
11wks |
|
2015 |
| | |
|
|
Pletcher1:1
|
|
|
(none)
|
TST
36001
|
inbred |
|
m |
7-10wks* |
|
2007 |
| | |
|
|
Schalkwyk1:31
|
|
|
(none)
|
dur_immobil
34531
trial 1 trial 2
|
inbred |
|
m |
9-11wks |
|
2010 |
| | |
|
|
Wiltshire2:1
|
|
|
fluoxetine
|
TST
38001
control fluoxetine
|
inbred |
|
m |
9-10wks |
|
2011 |
| | |
|
|